No reduction in pain control occurred in patients administered HHER at the end of the 24-hour dosing period.
Conclusions Although this is a small study, it suggests that esmolol is more effective in converting patients to normal sinus rhythm than diltiazem during the initial dosing period.
There were no significant differences between treatments in API scores or amount of rescue medication used at any time interval within the 24-hour dosing period.
Continual action of the compound over the dosing period was confirmed by constant plasma exposure, and a maintained change in urinary glucocorticoid metabolites consistent with 11β-HSD1 inhibition.
Milk yield tended to be greater during the dosing period in cows fed CL+SCFP compared with T (39.7 vs. 37.7 kg/d).
Neurological disease severity score and body weight were determined daily during the dosing period.
One of these subjects made this complaint during the 300 mg dosing period, two following the 1200 mg dosing period, and three following the 1800 mg dosing period.
Concomitant medications were those received during the clobazam dosing period.
Depot formulations were considered continuously over the whole dosing period.
Treatment group-related vocabularies were developed to establish the generation, gender, and dosing period.
The improvement in impulsiveness was maintained throughout the 14-day dosing period.
